A top Food and Drug Administration official warned vaccine makers that the agency could call upon rarely-used powers to disclose significant safety issues, after being asked about month-old investigation into an experimental Covid-19 shot from by
At an online event hosted by Johns Hopkins University and the University of Washington, FDA Center for Biologics Evaluation and Research Director Peter Marks said he “would encourage any manufacturers of a vaccine, any sponsor of a vaccine to be as transparent as possible.”
Marks emphasized that he was not talking specifically about any one company.
He followed up by invoking ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.